Tirzepatide: the dual GIP/GLP-1 agonist and what the research shows
How one molecule acts on two incretin receptors, what the SURPASS and SURMOUNT trial programmes found, and where tirzepatide sits between semaglutide and retatrutide.
Read article →Free delivery on orders over €70
Tirzepatide
Dual GIP/GLP-1 receptor agonist.
Purity
≥99% (HPLC)

Dual GIP/GLP-1 receptor agonist.
Price
Size
Tell me when it is back
Back-in-stock alerts are a club benefit.
Create a free accountFor laboratory and research use only. Not for human or veterinary use.
Tirzepatide is a dual GIP and GLP-1 receptor agonist used in research on combined GIP and GLP-1 receptor signalling in laboratory settings.
Recommended storage for this compound:
Handling guidance for laboratory use only. Not instructions for human or veterinary use.
The certificate for this size is being published — contact us for a copy in the meantime.
Size
The certificate for this size is being published — contact us for a copy in the meantime.
Contact